| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ibuprofen | FAERS: 6 | US FAERS | |
| 2 | Alprostadil | FAERS: 4 | US FAERS | |
| 3 | Fluoxetine | FAERS: 2 | US FAERS | |
| 4 | Acetaminophen | FAERS: 1 | US FAERS | |
| 5 | Bosentan | FAERS: 1 | US FAERS | |
| 6 | Cholic Acid | FAERS: 1 | US FAERS | |
| 7 | Etidronic Acid | FAERS: 1 | US FAERS | |
| 8 | Gabapentin | FAERS: 1 | US FAERS | |
| 9 | Liraglutide | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Losartan | FAERS: 1 | US FAERS | |
| 11 | Oxcarbazepine | FAERS: 1 | US FAERS | |
| 12 | Rifaximin | FAERS: 1 | US FAERS | |
| 13 | Vigabatrin | FAERS: 1 | US FAERS | |
| 14 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.